The company says it features a unique, tri-lipid gel-based formulation that increases absorption by up to tenfold.
Dietary supplements marketer Thorne Research Inc., which largely serves the healthcare practitioner market, has acquired exclusive global rights to market Q-Cell, which the company calls a high-bioavailability CoQ10 supplement.
The company says that Q-Cell, formerly marketed under the name Q-Best, features a unique, tri-lipid gel-based formulation that increases absorption by up to tenfold when compared with dry-powder CoQ10 supplements. The company says that Q-Cell’s formulation enables the soft gel to prevent crystallization, which can often disrupt the absorption process when metabolized in humans.
The Nutritional Outlook Podcast Episode 39: Nutritional Outlook's Ingredients to Watch in 2025
February 25th 2025In this episode, Nutritional Outlook interviews Scott Dicker, market insights director from market researcher SPINS, about ingredients and product categories nutraceutical and nutrition product manufacturers should watch in 2025.